Literature DB >> 15727944

Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions.

Christoph A Kahl1, Karen Pollok, Laura S Haneline, Kenneth Cornetta.   

Abstract

HIV-1-derived lentiviral vectors have been pseudotyped with various envelope glycoproteins to alter their host range. Previously, we found that envelope glycoproteins derived from the alphavirus Ross River virus (RRV) can pseudotype lentiviral vectors and mediate efficient transduction of a variety of epithelial and fibroblast-derived cell lines. In this study, we have investigated transduction of hematopoietic cells using RRV-pseudotyped vectors encoding the enhanced green fluorescent protein (EGFP). RRV-mediated transduction of human CD34+ cord blood cells and progenitors was very inefficient, even at multiplicities of infection of 100 (0.4% EGFP-positive progenitor colonies). Inefficient transduction was also observed in a variety of hematopoietic cell lines. However, two erythroleukemia-derived cell lines and monocytic cells that were driven to macrophage-like differentiation were moderately transduced. Transduction of hematopoietic cells with a control VSV-G-pseudotyped lentiviral vector was generally efficient, but unexpectedly decreased up to threefold upon stimulation of lymphocytic cell lines or primary murine bone marrow cells. Also, the tested hematopoietic cell lines were essentially nonpermissive for adeno-associated type 2 (AAV) vectors, and this was not affected by lineage, activity, or differentiation. Treatment of permissive 293 cells with proteases revealed that transduction with both the RRV- and the VSV-G-pseudotyped vectors in part depends on the presence of cell surface proteins. These results show a severely restricted ability of RRV glycoproteins to mediate transduction in hematopoietic cells that is likely due to specific receptor requirements that differ from those of VSV-G and AAV. Conversely, transduction with the VSV glycoprotein is affected by cellular activation more than widely believed. Our findings suggest that the envelope glycoproteins and culture conditions employed need to be carefully evaluated for each application. Furthermore, the uniquely restricted host range of RRV-pseudotyped vectors may aid in the design of novel cell-selective transduction strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727944     DOI: 10.1016/j.ymthe.2004.08.032

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  7 in total

Review 1.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

Review 2.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

3.  Functional pseudotyping of human immunodeficiency virus type 1 vectors by Western equine encephalitis virus envelope glycoprotein.

Authors:  Ananthalakshmi Poluri; Rebecca Ainsworth; Scott C Weaver; Richard E Sutton
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

4.  Lentivirus Manufacturing Process for Primary T-Cell Biofactory Production.

Authors:  Harikrishnan Radhakrishnan; Harold S Javitz; Parijat Bhatnagar
Journal:  Adv Biosyst       Date:  2020-05-10

5.  Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domain.

Authors:  David M Markusic; Niek P van Til; Johan K Hiralall; Ronald P J Oude Elferink; Jurgen Seppen
Journal:  BMC Biotechnol       Date:  2009-10-07       Impact factor: 2.563

6.  Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex.

Authors:  Lisa Henss; Constanze Yue; Joshua Kandler; Helen M Faddy; Graham Simmons; Marcus Panning; Lia Laura Lewis-Ximenez; Sally A Baylis; Barbara S Schnierle
Journal:  Viruses       Date:  2019-01-18       Impact factor: 5.048

Review 7.  Current status on the development of pseudoviruses for enveloped viruses.

Authors:  Qianqian Li; Qiang Liu; Weijin Huang; Xuguang Li; Youchun Wang
Journal:  Rev Med Virol       Date:  2017-12-07       Impact factor: 6.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.